Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

被引:4
|
作者
Huang, Chung-Feng [1 ,2 ]
Huang, Ching-I [1 ,3 ]
Yeh, Ming-Lun [3 ]
Huang, Jee-Fu [3 ,4 ]
Hsieh, Ming-Yen [3 ]
Lin, Zu-Yau [3 ,4 ]
Chen, Shinn-Cherng [3 ,4 ]
Yu, Ming-Lung [3 ,4 ]
Dai, Chia-Yen [3 ,4 ,5 ,6 ]
Chuang, Wan-Long [3 ,4 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan
来源
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES | 2015年 / 31卷 / 05期
关键词
Genotype; Hepatitis C virus; Interleukin-28B; Mixed infection; INTERLEUKIN-28B GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; VIRAL-HEPATITIS; HCV; INTERFERON; IL28B; SUPERINFECTION; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.kjms.2015.02.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The prevalence and characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection (HCV-1/ 2) remains unclear. For each HCV-1/ 2 patient with histological data available, two age-and sex-matched HCV-1 and HCV-2 infected patients were selected for comparison, respectively. Of the 2776 patients, 261 (9.4%) patients were identified as having mixed HCV-1/ 2 infection. The histological severity did not differ among HCV-1/ 2 patients and controls. The proportion of patients with the interleukin-28B (IL-28B) rs8099917 TT genotype did not differ between patients with mixed-1/ 2 and HCV-1 infection (82.6% vs. 86.5%, p = 0.38). However, HCV-2 infected patients had a significantly higher proportion of the rs8099917 TT genotype compared to patients with mixed HCV-1/ 2 infections (91.6% vs. 82.6%, p = 0.03). The HCV RNA levels were similar in patients with HCV-1/ 2 and HCV-1 infections (5.5 +/- 0.8 log IU/mL vs. 5.5 +/- 0.9 log IU/L, p = 0.73), which were both significantly higher than that of HCV-2 infection (5.1 +/- 0.9 log IU/mL, both p < 0.001). Linear regression analysis revealed that the factors of HCV-1/2 infection [beta: 0.204; 95% confidence interval (CI): 0.183-0.598, p < 0.001], bodyweight(beta:0.150;CI: 0.003-0.021, p = 0.008), and age (beta: - 0.139; CI: - 0.020 to - 0.002, p = 0.01) were independently correlated with HCV RNA levels in patients with HCV-2 and mixed HCV-1/2 infection. We concluded that the host genetic and viral presentations of patients with mixed HCV-1/2 infection were more similar to those of patients with HCV-1 infection than patients with HCV-2 infection. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [31] GB virus C and hepatitis C virus infection in patients with mixed cryoglobulinemia
    Morsica, G
    Sitia, G
    Roccatello, D
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (05) : 394 - 395
  • [32] Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients
    Brown, Kristen
    LaBrie, Martin
    Coffin, Carla S.
    CURRENT HIV/AIDS REPORTS, 2013, 10 (04) : 420 - 427
  • [33] Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients
    Kristen Brown
    Martin LaBrie
    Carla S. Coffin
    Current HIV/AIDS Reports, 2013, 10 : 420 - 427
  • [34] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Toshifumi Tada
    Takashi Kumada
    Hiroaki Okushin
    Joji Tani
    Koichi Takaguchi
    Akemi Tsutsui
    Hidenori Toyoda
    Satoshi Yasuda
    Kazufumi Dohmen
    Atsushi Hiraoka
    Kojiro Michitaka
    Kazuhiro Nouso
    Kazuya Kariyama
    Soo Ryang Kim
    Soo Ki Kim
    Shinichi Fujioka
    Shigeru Mikami
    Yuto Watanabe
    Tsutomu Tamai
    Masanori Atsukawa
    Norio Itokawa
    Hironori Tanaka
    Kunihiko Tsuji
    Toru Ishikawa
    Michitaka Imai
    Ei Itobayashi
    Hiroshi Shibata
    Noritomo Shimada
    Infectious Diseases and Therapy, 2021, 10 : 269 - 280
  • [35] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Tada, Toshifumi
    Kumada, Takashi
    Okushin, Hiroaki
    Tani, Joji
    Takaguchi, Koichi
    Tsutsui, Akemi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Dohmen, Kazufumi
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Nouso, Kazuhiro
    Kariyama, Kazuya
    Kim, Soo Ryang
    Kim, Soo Ki
    Fujioka, Shinichi
    Mikami, Shigeru
    Watanabe, Yuto
    Tamai, Tsutomu
    Atsukawa, Masanori
    Itokawa, Norio
    Tanaka, Hironori
    Tsuji, Kunihiko
    Ishikawa, Toru
    Imai, Michitaka
    Itobayashi, Ei
    Shibata, Hiroshi
    Shimada, Noritomo
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 269 - 280
  • [36] HEPATITIS-C VIRUS GENOTYPE IN PATIENTS WITH ESSENTIAL MIXED CRYOGLOBULINEMIA
    SINICO, RA
    RIBERO, ML
    FORNASIERI, A
    RENOLDI, P
    ZHOU, J
    FASOLA, M
    PORTERA, G
    ARRIGO, G
    GIBELLI, A
    DAMICO, G
    TAGGER, A
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1995, 88 (11): : 805 - 810
  • [37] The efficacy of sofosbuvir and ribavirin in patients with chronic hepatitis C virus genotype 2 infection
    Kwan, Byung Soo
    Shim, Sang Goon
    Yu, Kil Jong
    Cho, Dae Hyeon
    Oh, Ji Eun
    Jeong, Chang Wook
    Kim, Kwang Min
    Lee, Hyoun Soo
    Lee, Jung Won
    Lee, Dong Kyu
    Choi, Ik Sung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 439 - 439
  • [38] Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients
    Huang, Chung-Feng
    Dai, Chia-Yen
    Yeh, Ming-Lun
    Huang, Jee-Fu
    Huang, Ching-I
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Wang, Liang-Yen
    Juo, Suh-Hang Hank
    Chuang, Wan-Long
    Lin, Yi-Ching
    Yu, Ming-Lung
    PLOS ONE, 2013, 8 (03):
  • [39] Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin
    Su, Pei-yuan
    Yen, Hsu-Heng
    Hsu, Yu-Chun
    Wu, Shun-Sheng
    Kor, Chew-Teng
    Su, Wei-Wen
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2016, 32 (07): : 381 - 386
  • [40] Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C:: implications for treatment
    Pérez-Olmeda, M
    Ríos, P
    Núñez, M
    García-Samaniego, J
    Romero, M
    Soriano, V
    AIDS, 2002, 16 (03) : 493 - 495